Right-heart strain does not separate amniotic fluid embolism (AFE) from massive pulmonary embolism (PE): either can cause acute hypoxemia, shock, and cardiovascular collapse. Among bedside clues, overt coagulopathy that develops early—before blood loss or resuscitation is sufficient to explain it—most favors AFE over isolated thrombotic PE.
That is a probability-shifting clue, not a stand-alone diagnosis. In an obstetric emergency, the timeline and the competing causes of abnormal clotting matter as much as the lab result itself.
Why clotting changes the differential
A massive PE is an obstructive event: thrombus raises pulmonary vascular resistance, strains the right ventricle, and can sharply reduce cardiac output. That explains collapse, but rapidly developing disseminated intravascular coagulation (DIC) is not a typical defining feature of PE.
AFE can produce the same cardiopulmonary crisis, and often includes systemic coagulation activation and consumptive coagulopathy. Its precise pathophysiology is not fully settled; avoid reducing AFE to the idea that fetal material simply plugs pulmonary arteries. In the appropriate peripartum setting, early DIC without a better explanation therefore points toward AFE more strongly than RV strain or hypoxemia does.
| Finding | How it shifts the differential |
|---|---|
| Sudden hypoxemia, hypotension, or arrest | Compatible with both AFE and massive PE |
| Acute RV strain | Compatible with both; it does not identify the cause |
| Overt DIC before blood loss is sufficient to account for it, often appearing as diffuse bleeding soon after collapse | Strongly favors AFE over isolated PE |
| Coagulation abnormalities after major hemorrhage, large-volume resuscitation, or prolonged shock | Less discriminating; these events can themselves cause or worsen coagulopathy |
Oozing from IV sites can make the pattern visible at the bedside. But bleeding is not specific: postpartum hemorrhage can cause shock and coagulopathy, and bleeding may occur alongside another cause of cardiopulmonary collapse. The useful question is not simply, “Is she bleeding?” It is, “When did the bleeding and coagulation abnormality begin relative to the collapse and blood loss?”
Read the timeline before labeling the labs
Build a short sequence: the time of labor or placental delivery; the first respiratory or hemodynamic change; the onset of bleeding; and when fluids, blood products, or anticoagulants were given. Ask about placental abruption, uterine atony, trauma, hypertensive pregnancy disease, infection or fever, anesthesia events, and VTE risks such as prior VTE or anticoagulant use. Relevant cardiac or pulmonary disease and baseline function can also change how the presentation should be interpreted. If these details are missing, keep the diagnosis conditional.
Then assess coagulation in context. Send a CBC with platelet count, PT/INR, and fibrinogen early, and trend results if the patient remains unstable or bleeding. A falling fibrinogen or platelet count and worsening clotting times can support consumption, but a single value cannot establish the cause. Pregnancy changes the baseline: fibrinogen is normally elevated late in pregnancy, so a low or rapidly falling result may be more concerning than a value that looks only modestly abnormal by a nonpregnant reference range.
The proposed research case definition for AFE requires all four criteria for research classification: sudden cardiorespiratory arrest, or hypotension with respiratory compromise; overt DIC following the initial signs, documented using a pregnancy-modified ISTH score and detected before blood loss is sufficient to account for dilutional or shock-related coagulopathy; clinical onset during labor or within 30 minutes of placental delivery; and no fever during labor. These criteria are intended to standardize research reporting, not to serve as a stand-alone bedside diagnostic rule. Atypical clinical cases may not meet them.
Keep supportive findings in their lane
Seizure, confusion, or loss of consciousness can occur during AFE, but they do not outweigh the clotting timeline as a discriminator. Severe hypoxemia and poor cerebral perfusion can also cause neurologic findings in massive PE. Similarly, echo evidence of RV dysfunction may clarify the physiology and guide urgent care, but does not by itself tell you whether the cause is AFE or thrombotic PE.
There is no specific laboratory test that confirms or rules out AFE. A normal early coagulation panel does not settle the differential, particularly if the syndrome is evolving; conversely, abnormal coagulation tests do not prove AFE when hemorrhage, placental disease, sepsis, or another cause could explain them. Research criteria use a defined combination of timing, cardiopulmonary compromise, and DIC—not one isolated clue.
For the emergency team, the practical response is to timestamp the clinical events, repeat the relevant labs as indicated, and involve obstetrics, anesthesia, critical care, and the blood bank early when bleeding or coagulopathy is emerging. Continue evaluating other dangerous causes, including PE, in parallel. A clue that favors AFE should refine the differential, not prematurely close it or determine treatment by itself.
Practical takeaways
- When asked which feature most strongly supports AFE over massive PE, answer early overt DIC or coagulopathy, especially before blood loss or resuscitation is sufficient to explain it.
- Hypoxemia, shock, cardiac arrest, and RV strain can occur with either diagnosis.
- Interpret clotting results against pregnancy physiology and the timing of hemorrhage, fluids, transfusion, and anticoagulants.
- AFE remains a clinical diagnosis; no single lab test confirms it, and coagulopathy alone is not specific.
- Keep PE and other reversible causes in the differential while the team stabilizes the patient and clarifies the timeline.
